XTL Biopharmaceuticals Ltd. Sponsored ADR(NASDAQ : XTLB)
(
)
Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| CELG | Celgene Corporation | -1.65% | 88.15 | 1.3% | $855.06m | |
| AMGN | Amgen Inc. | -2.71% | 186.70 | 1.2% | $536.92m | |
| BIIB | Biogen Inc. | -4.48% | 216.71 | 1.3% | $511.45m | |
| ONCE | Spark Therapeutics, Inc. | -0.24% | 113.00 | 11.2% | $460.68m | |
| GILD | Gilead Sciences, Inc. | -1.77% | 63.77 | 0.9% | $455.57m | |
| REGN | Regeneron Pharmaceuticals, Inc. | -2.68% | 391.80 | 2.6% | $275.42m | |
| ILMN | Illumina, Inc. | -3.26% | 308.79 | 3.5% | $273.28m | |
| VRTX | Vertex Pharmaceuticals Incorporated | -0.56% | 181.53 | 1.9% | $235.95m | |
| BPTH | Bio-Path Holdings, Inc. | 18.94% | 21.98 | 190.1% | $220.64m | |
| SRPT | Sarepta Therapeutics, Inc. | -3.47% | 122.26 | 15.4% | $207.36m | |
| EXAS | Exact Sciences Corporation | -3.28% | 89.00 | 25.3% | $185.14m | |
| ALXN | Alexion Pharmaceuticals, Inc. | -2.98% | 130.21 | 2.0% | $179.59m | |
| A | Agilent Technologies, Inc. | -3.68% | 78.98 | 1.6% | $135.89m | |
| IONS | Ionis Pharmaceuticals, Inc. | -1.99% | 78.90 | 8.3% | $104.26m | |
| INCY | Incyte Corporation | -2.00% | 85.34 | 2.5% | $93.76m |
Company Profile
XTL Biopharmaceuticals Ltd is a biopharmaceutical company, which engages in the acquisition and development of pharmaceutical drugs. Its drug development program focuses on the treatment of systemic lupus erythematosus. The company was founded on March 9, 1993 and is headquartered in Ramat Gan, Israel.